KILITCH.BO

Kilitch Drugs (India) Limited operates as a pharmaceutical enterprise primarily within India, with an active presence in international markets through product exports. Established in Mumbai in 1978, the company manufactures a diverse portfolio of healthcare solutions. Its extensive range of parenteral and nasal formulations addresses various medical needs, including gastroenterology, anti-inflammatory conditions, epilepsy, malaria, bacterial infections, hypertension, and oncology, alongside diagnostic, anesthetic, and ophthalmic treatments. This segment also encompasses vaccines, veterinary products, iron supplements for anemia, and metered nasal drops, available as liquid ampoules, vials, and dry powder injectables, featuring brands like Klavmox and Onecef. Beyond injectables, Kilitch provides a comprehensive selection of oral medications, such as tablets, capsules, dry syrups, gripe water, and liquids, targeting antibiotics, anti-diabetic, and cardiovascular therapeutic areas, among others. The company also produces effervescent tablets and powders, exemplified by ROIPAR, DUREGRA, ROIVIT, and PH-7, in addition to nutritional supplements like CELTINE. Furthermore, Kilitch offers specialty products like C-Seal, a topical skin adhesive designed to facilitate suture-free wound closure. Their product offerings extend into cosmetics and herbal remedies, featuring a variety of oils, lotions, creams, and pastes for skin, personal, and hair care. The herbal line includes solutions for sore throats, prostate health, and supplementary support for conditions such as diabetes, obesity, and libido.